CONTACT US
Home > Inhibitors/Agonists> > Bromolysergide
478-84-2-Bromolysergide Bromolysergide

Bromolysergide

For research use only. Not for therapeutic Use.

  • CAT Number: I023724
  • CAS Number: 478-84-2
  • Molecular Formula: C20H24BrN3O
  • Molecular Weight: 402.336
  • Purity: 98%
Inquiry Now
Related Small Molecules: Tsugaric acid A     Syringaresinol     Fasudil    

Bromolysergide is discontinued (DEA controlled substance). Bromolysergide is a serotonin antagonist.


Catalog Number I023724
CAS Number 478-84-2
Synonyms

Bromolysergide; BOL

Molecular Formula C20H24BrN3O
Purity 98%
Solubility Soluble in DMSO
Appearance Solid powder
Storage Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
IUPAC Name Ergoline-8-carboxamide, 2-bromo-9,10-didehydro-N,N-diethyl-6-methyl-, (8beta)-
InChI InChI=1S/C20H24BrN3O/c1-4-24(5-2)20(25)12-9-14-13-7-6-8-16-18(13)15(19(21)22-16)10-17(14)23(3)11-12/h6-9,12,17,22H,4-5,10-11H2,1-3H3/t12-,17-/m1/s1
InChIKey VKRAXSZEDRWLAG-SJKOYZFVSA-N
SMILES [H][C@@]1(N(C)C[C@H](C(N(CC)CC)=O)C=C12)CC3=C(Br)NC4=C3C2=CC=C4
Reference

1: Harvey JA, Gormezano I, Cool VA. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response. J Pharmacol Exp Ther. 1982 May;221(2):289-94. PubMed PMID: 6122729.
2: Brandon JM. Failure of indomethacin and D-2-Bromolysergic acid diethylamide to modify the acute oedematous reaction to oestradiol in the uterus of the immature rat. J Endocrinol. 1978 Aug;78(2):291-2. PubMed PMID: 29933.
3: BERTINO JR, KLEE GD, WEINTRAUB W. Cholinesterase, dlysergic acid diethylamide, and 2-bromolysergic acid diethylamide. J Clin Exp Psychopathol Q Rev Psychiatry Neurol. 1959 Jul-Sep;20:218-22. PubMed PMID: 13799991.
4: Persson SA, Johansson H. The effect of lysergic and diethylamide (LSD) and 2-bromolysergic acid diethylamide (BOL) on the striatal DOPA accumulation: influence of central 5-hydroxytryptaminergic pathways. Brain Res. 1978 Mar 10;142(3):505-13. PubMed PMID: 25117.
5: Green JP, Johnson CL, Weinstein H, Maayani S. Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5697-701. PubMed PMID: 23536; PubMed Central PMCID: PMC431860.
6: Zivin JA, Venditto JA. Experimental CNS ischemia: serotonin antagonists reduce or prevent damage. Neurology. 1984 Apr;34(4):469-74. PubMed PMID: 6142430.
7: King LA, Ujváry I, Brandt SD. Drug laws and the ‘derivative’ problem. Drug Test Anal. 2014 Jul-Aug;6(7-8):879-83. doi: 10.1002/dta.1523. Epub 2013 Aug 15. PubMed PMID: 23949903.
8: Lin RC, Ngai SH, Costa E. Lysergic acid diethylamide: role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine). Science. 1969 Oct 10;166(3902):237-9. PubMed PMID: 5809595.
9: Karst M, Halpern JH, Bernateck M, Passie T. The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series. Cephalalgia. 2010 Sep;30(9):1140-4. doi: 10.1177/0333102410363490. Epub 2010 Mar 26. PubMed PMID: 20713566.
10: Paegelow I, Lange P. Pharmacological studies on lymphocytes: 2. Effects of indole derivatives and their antagonists on the lymphocyte migration. Agents Actions. 1984 Oct;15(3-4):361-6. PubMed PMID: 6084414.
11: Tutton PJ, Barkla DH. The influence of serotonin on the mitotic rate in the colonic crypt epithelium and in colonic adenocarcinoma in rats. Clin Exp Pharmacol Physiol. 1978 Jan-Feb;5(1):91-4. PubMed PMID: 25153.
12: Harvey JA. Role of the serotonin 5-HT(2A) receptor in learning. Learn Mem. 2003 Sep-Oct;10(5):355-62. Review. PubMed PMID: 14557608; PubMed Central PMCID: PMC218001.
13: Cunningham KA, Appel JB. Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD). Psychopharmacology (Berl). 1987;91(1):67-73. PubMed PMID: 3103161.
14: KRIVOY WA. The preservation of substance P by lysergic acid diethylamide. Br J Pharmacol Chemother. 1957 Sep;12(3):361-4. PubMed PMID: 13460245; PubMed Central PMCID: PMC1509706.
15: Walker EA, Foley JJ. Acquisition session length modulates consolidation effects produced by 5-HT2C ligands in a mouse autoshaping-operant procedure. Behav Pharmacol. 2010 Mar;21(2):83-9. doi: 10.1097/FBP.0b013e328337bde7. PubMed PMID: 20177374.
16: Whipple MR, Reinecke MG, Gage FH. Inhibition of synaptosomal neurotransmitter uptake by hallucinogens. J Neurochem. 1983 Apr;40(4):1185-8. PubMed PMID: 6131933.
17: Gaitondé BB, Joglekar SN. Mechanism of neurotoxicity of cardiotonic glycosides. Br J Pharmacol. 1977 Feb;59(2):223-9. PubMed PMID: 13903; PubMed Central PMCID: PMC1667725.
18: ISBELL H, MINER EJ, LOGAN CR. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25). Psychopharmacologia. 1959 Nov 3;1:109-16. PubMed PMID: 14405871.
19: Dhumal VR, Gulati OD, Raghunath PR, Sivaramakrishna N. Analysis of the effects on body temperature of intracerebroventricular injection in anaesthetized dogs of gamma-aminobutyric acid. Br J Pharmacol. 1974 Apr;50(4):513-24. PubMed PMID: 4155652; PubMed Central PMCID: PMC1776733.
20: Harvey JA, Welsh SE, Hood H, Romano AG. Effect of 5-HT2 receptor antagonists on a cranial nerve reflex in the rabbit: evidence for inverse agonism. Psychopharmacology (Berl). 1999 Jan;141(2):162-8. PubMed PMID: 9952040.

Request a Quote